Phase 3 Vulvar Cancer Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Cervical CancerVaginal CancerVulvar Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd.8,000 enrolled1 locationNCT04422366
Recruiting
Phase 3
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
Cervical CancerVaginal CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd.1,200 enrolled1 locationNCT04895020